ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.98293
0.06%
Brent Oil
83.795
0.20%
Bitcoin
59,563.56
0.75%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Outlook Therapeutics Inc (OTLK)

  7. Outlook Therapeutics Inc (OTLK) Noticias

OTLK Outlook Therapeutics Inc

8.49
-0.01 (-0.12%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Outlook Therapeutics Inc OTLK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.01 -0.12% 8.49 18:59:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.60 8.2703 8.605 8.49 8.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202408:05GLOBEOutlook Therapeutics® to Present at the Retina World..
29/4/202408:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
15/4/202415:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22/3/202406:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
18/3/202416:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12/3/202407:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
11/3/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:16EDGAR2Form 8-K - Current report
14/2/202416:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202415:40EDGAR2Form 8-K - Current report
14/2/202407:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
08/2/202406:00EDGAR2Form ARS - Annual Report to Security Holders
08/2/202405:59EDGAR2Form DEF 14A - Other definitive proxy statements
31/1/202415:01EDGAR2Form SC 13D/A - General statement of acquisition of..
31/1/202407:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
29/1/202416:00EDGAR2Form PRE 14A - Other preliminary proxy statements
24/1/202416:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/1/202405:02EDGAR2Form 8-K - Current report
23/1/202407:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
22/12/202316:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/12/202315:15EDGAR2Form 8-K - Current report
22/12/202307:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
19/12/202307:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
18/12/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06/12/202316:00EDGAR2Form 8-K - Current report
06/12/202307:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
04/12/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
29/11/202315:01EDGAR2Form SC 13D/A - General statement of acquisition of..
28/11/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202307:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
21/11/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202307:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
14/11/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202307:12EDGAR2Form 8-K - Current report
02/11/202307:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
01/11/202307:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..
20/10/202316:00EDGAR2Form 8-K - Current report
05/10/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202307:05GLOBEOutlook Therapeutics® Requests Type A Meeting With FDA
21/9/202307:05GLOBEOutlook Therapeutics® to Present at the 2023 Cantor..
05/9/202307:05GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 25th..
30/8/202305:21EDGAR2Form 8-K - Current report
30/8/202305:00GLOBEOutlook Therapeutics® Provides Regulatory Update on FDA..

Su Consulta Reciente

NASDAQ
OTLK
Outlook Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados